USPSTF recommends aspirin for prevention of colorectal cancer

Share this content:

the ONA take:

For the first time, the United States Preventive Services Task Force (USPSTF) has issued a broad recommendation to take aspirin to prevent colorectal cancer.

In the draft report, the task force found that low-dose or baby aspirin can help prevent heart attacks, stroke, and colorectal cancer, particularly in high-risk people in their 50’s.

An analysis on colorectal cancer found that aspirin use reduced colorectal cancer-related deaths by 33% and reduced colon cancer incidence by 40%; however, people need to take aspirin for at least 5 to 10 years in order to have a benefit.

“No major health organization has previously recommended the use of aspirin to prevent cancer,” Dr. Eric Jacobs of the American Cancer Society said. “This is a new approach that makes a great deal of sense.”

However, not everyone feels positively about these new recommendations. “People still need to be screened,” Dr. David Johnson of the United Stated Multi-Society Task Force on Colorectal Cancer said. “I have major reservations that the message will be, ‘I take aspirin, so I don’t need to be screened.’”

According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related deaths in the United States in men and women separately and the second leading cause when combined.

In a First, Aspirin Is Recommended to Fight a Form of Cancer
The USPSTF has issued a broad recommendation to take aspirin to prevent colorectal cancer.
For years, doctors have recommended daily aspirin to lower cardiovascular risk in certain men and women. Now, for the first time, an expert panel is recommending aspirin therapy to prevent heart attacks and colorectal cancer.
READ FULL ARTICLE From The New York Times
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs